Propanolol



Indications and Reactions:

Role Indications Reactions
Primary
Panic Disorder 50.0%
Aggression 25.0%
Reading Disorder 25.0%
Toxicity To Various Agents 25.0%
Overdose 12.5%
Respiratory Arrest 12.5%
Tachycardia 12.5%
Treatment Noncompliance 12.5%
Tremor 12.5%
Wound 12.5%
Secondary
Product Used For Unknown Indication 29.5%
Depression 6.6%
Gastrooesophageal Reflux Disease 6.6%
Heart Rate Increased 6.6%
Hypertension 6.6%
Chronic Obstructive Pulmonary Disease 4.9%
Migraine 4.9%
Parkinson's Disease 4.9%
Anxiety 3.3%
Asthma 3.3%
Low Density Lipoprotein Increased 3.3%
Prophylaxis 3.3%
Urinary Tract Infection 3.3%
Wolff-parkinson-white Syndrome 3.3%
Atrial Flutter 1.6%
Autoimmune Thyroiditis 1.6%
Bladder Disorder 1.6%
Blood Pressure Abnormal 1.6%
Fibromyalgia 1.6%
Gastric Disorder 1.6%
Dyspnoea 10.0%
Intentional Overdose 10.0%
Unevaluable Event 10.0%
Completed Suicide 5.0%
Hemianopia 5.0%
Liposarcoma 5.0%
Muscle Contractions Involuntary 5.0%
Oxygen Saturation Decreased 5.0%
Poisoning 5.0%
Premature Baby 5.0%
Rash 5.0%
Raynaud's Phenomenon 5.0%
Tinnitus 5.0%
Ventricular Tachycardia 5.0%
Vitamin D Decreased 5.0%
Weight Decreased 5.0%
Weight Increased 5.0%
Concomitant
Product Used For Unknown Indication 36.9%
Hypertension 13.0%
Rheumatoid Arthritis 5.6%
Pain 4.1%
Anxiety 3.9%
Gastrooesophageal Reflux Disease 3.8%
Migraine 3.8%
Depression 3.7%
Tremor 3.5%
Sleep Disorder 2.8%
Diabetes Mellitus 2.5%
Blood Cholesterol Increased 2.3%
Chronic Obstructive Pulmonary Disease 2.0%
Crohn's Disease 2.0%
Vitamin Supplementation 2.0%
Cardiac Disorder 1.7%
Hypothyroidism 1.7%
Multiple Sclerosis 1.7%
Prophylaxis 1.5%
Blood Pressure 1.3%
Vomiting 12.6%
Weight Decreased 11.6%
Weight Increased 10.5%
Urinary Tract Infection 6.3%
Suicidal Ideation 5.3%
Tremor 5.3%
Off Label Use 4.2%
Pain 4.2%
Pain In Extremity 4.2%
Pyrexia 4.2%
Death 3.2%
Drug Ineffective 3.2%
Haematemesis 3.2%
Incorrect Dose Administered 3.2%
Injection Site Pain 3.2%
Nausea 3.2%
Pulmonary Embolism 3.2%
Rheumatoid Arthritis 3.2%
Syncope 3.2%
Tachycardia 3.2%
Interacting
Anaphylactic Reaction 75.0%
Migraine 25.0%
Potentiating Drug Interaction 100.0%